Australian rheumatology patients will be the subjects of a worrying “world first” experiment if pharmacists are permitted to substitute biologics for biosimilars, the ARA warns. President Mona Marabani appeared at a Senate Economics Committee hearing on Thursday to voice concerns about the government’s move to save $800 million by allowing pharmacists to substitute biosimilars for ...
Updated: Australian patients part of a world first experiment
By Nicola Garrett
23 Jun 2015